On May 23, 2025, Novartis AG (NYSE:NVS) stock closed at $112.75 per share with a market capitalization of $227.204 billion.

Over the past year, NVS's P/B has been as high as 3.46 and as low as 2.62, with a median of 3.02. Value investors also use the P/S ratio. The P/S ratio is is calculated as price divided by sales.

NVS sits at a Zacks Rank #3 (Hold), holds a Value Style Score of B, and has a VGM Score of A. Compared to the Large Cap Pharmaceuticals industry's P/E of 14.6X, shares of Novartis are trading at a ...

Another notable valuation metric for NVS is its P/B ratio of 4.46. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities.

Novartis AG (NYSE:NVS) is a Swiss pharmaceutical company that is one of the largest of its kind. Its shares have gained 17% year-to-date, but the shares lost 2.5% in July after the firm’s fiscal ...

Founded by Jason Havens in 2011, NVS is an office space planning and project management service, helping businesses plan their moves or office redesigns from start to finish.